Parallel Advisors LLC Purchases 845 Shares of Church & Dwight Co., Inc. (NYSE:CHD)

Parallel Advisors LLC boosted its position in Church & Dwight Co., Inc. (NYSE:CHD) by 8.7% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 10,528 shares of the company’s stock after acquiring an additional 845 shares during the period. Parallel Advisors LLC’s holdings in Church & Dwight were worth $1,159,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of Church & Dwight by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 30,691,064 shares of the company’s stock worth $3,213,661,000 after purchasing an additional 193,602 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Church & Dwight by 19.4% in the 4th quarter. JPMorgan Chase & Co. now owns 7,336,046 shares of the company’s stock worth $768,157,000 after buying an additional 1,190,154 shares during the period. Geode Capital Management LLC boosted its holdings in Church & Dwight by 2.6% in the 4th quarter. Geode Capital Management LLC now owns 5,915,390 shares of the company’s stock worth $617,794,000 after buying an additional 148,234 shares during the period. Stifel Financial Corp grew its stake in Church & Dwight by 0.5% in the 4th quarter. Stifel Financial Corp now owns 4,316,414 shares of the company’s stock valued at $451,975,000 after buying an additional 20,887 shares in the last quarter. Finally, Norges Bank bought a new stake in Church & Dwight during the 4th quarter valued at $318,532,000. 86.60% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CHD has been the topic of several recent research reports. Evercore ISI dropped their target price on Church & Dwight from $106.00 to $102.00 and set an “in-line” rating on the stock in a research report on Friday, May 2nd. TD Cowen cut Church & Dwight from a “buy” rating to a “hold” rating and set a $100.00 price objective on the stock. in a report on Tuesday, May 6th. Truist Financial raised their target price on Church & Dwight from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Monday, February 3rd. Cowen cut Church & Dwight from a “buy” rating to a “hold” rating in a research report on Tuesday, May 6th. Finally, Morgan Stanley lowered their price target on shares of Church & Dwight from $110.00 to $100.00 and set an “equal weight” rating on the stock in a report on Monday, May 5th. Three analysts have rated the stock with a sell rating, eight have given a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $109.13.

Insider Activity at Church & Dwight

In other Church & Dwight news, EVP Maynadier Patrick D. De sold 54,510 shares of the company’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $115.98, for a total value of $6,322,069.80. Following the completion of the sale, the executive vice president now owns 10,497 shares of the company’s stock, valued at $1,217,442.06. This represents a 83.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Rene Hemsey sold 11,060 shares of the stock in a transaction that occurred on Wednesday, March 12th. The shares were sold at an average price of $109.98, for a total transaction of $1,216,378.80. Following the transaction, the executive vice president now owns 6,437 shares in the company, valued at $707,941.26. The trade was a 63.21% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 83,230 shares of company stock valued at $9,197,884 over the last 90 days. 2.00% of the stock is owned by insiders.

Church & Dwight Stock Up 0.3%

Shares of NYSE CHD opened at $98.45 on Monday. The company has a current ratio of 1.70, a quick ratio of 1.24 and a debt-to-equity ratio of 0.51. The business has a 50-day moving average of $100.08 and a 200-day moving average of $104.72. The firm has a market capitalization of $24.25 billion, a price-to-earnings ratio of 41.54, a PEG ratio of 3.32 and a beta of 0.55. Church & Dwight Co., Inc. has a 12 month low of $90.99 and a 12 month high of $116.46.

Church & Dwight (NYSE:CHD) last released its quarterly earnings results on Thursday, May 1st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. The business had revenue of $1.47 billion during the quarter, compared to analysts’ expectations of $1.52 billion. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. The business’s quarterly revenue was down 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.96 EPS. Sell-side analysts expect that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current fiscal year.

Church & Dwight Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 2nd. Investors of record on Thursday, May 15th will be given a $0.295 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.18 annualized dividend and a yield of 1.20%. Church & Dwight’s dividend payout ratio (DPR) is presently 50.64%.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.